Xianhua Xu

发表

ERCC1 predicts a poorer platinum-based chemotherapy outcome but a better outcome for uracil-tegafur in the resected stage I-II NSCLC

H. Ryu, Hyojin Kim, Jin-Haeng Chung, 2011 .

Aberration of the Wnt signaling pathway in pulmonary fatal adenocarcinoma: a case report.

Xianhua Xu, Junzhe Li, X. Bai, 2014, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

Overexpression of epithelial-mesenchymal transition-related markers according to cell dedifferentiation: clinical implications as an independent predictor of poor prognosis in cholangiocarcinoma.

H. Ryu, Ja-june Jang, Haeryoung Kim, 2012, Human pathology.

Clinical and molecular evidences of epithelial to mesenchymal transition in acquired resistance to EGFR-TKIs.

C. Lee, H. Yoon, Yunjung Choi, 2011, Lung cancer.

Aberrant Wnt1/&bgr;-Catenin Expression is an Independent Poor Prognostic Marker of Non-small Cell Lung Cancer After Surgery

C. Lee, Jin-Haeng Chung, P. Sun, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Clinicopathologic Implications of ALK Gene Copy Number Gain in Non-small Cell Lung Cancer.

Yan-Ze Jin, C. Lee, Hyojin Kim, 2011 .

Immunohistochemical demonstration of alteration of β-catenin during tumor metastasis by different mechanisms according to histology in lung cancer

Yan-Ze Jin, Hyojin Kim, Jin-Haeng Chung, 2014, Experimental and therapeutic medicine.

Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas: Comparison of four commercially available antibodies by immunohistochemistry and fluorescence in situ hybridization study.

Jae Ho Lee, H. Lee, C. Lee, 2010, Lung cancer.

Trends in Molecular Testing of Lung Cancer in Mainland People’s Republic of China Over the Decade 2010 to 2019

Xia Li, Jie Ma, Y. Xi, 2021, JTO clinical and research reports.

High Incidence of EGFR Mutations in Korean Men Smokers with No Intratumoral Heterogeneity of Lung Adenocarcinomas: Correlation with Histologic Subtypes, EGFR/TTF-1 Expressions, and Clinical Features

H. Lee, C. Lee, H. Seol, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Detection of ALK Gene Rearrangement in Non-small Cell Lung Cancer: A Comparison of Fluorescence In Situ Hybridization and Chromogenic In Situ Hybridization with Correlation of ALK Protein Expression

T. Grogan, C. Lee, H. Nitta, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Clinicopathological correlations of mTOR and pAkt expression in non-small cell lung cancer

H. Lee, C. Lee, Jin-Haeng Chung, 2012, Virchows Archiv.

Comparison of Direct Sequencing, PNA Clamping-Real Time Polymerase Chain Reaction, and Pyrosequencing Methods for the Detection of EGFR Mutations in Non-small Cell Lung Carcinoma and the Correlation with Clinical Responses to EGFR Tyrosine Kinase Inhibitor Treatment

H. Lee, Yan-Ze Jin, Hyojin Kim, 2013, Korean journal of pathology.

The Accuracy of Frozen Section Diagnosis of Pulmonary Nodules: Evaluation of Inflation Method during Intraoperative Pathology Consultation with Cryosection

Jae Ho Lee, C. Lee, G. Choe, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Overexpression of Wnt7a enhances radiosensitivity of non-small-cell lung cancer via the Wnt/JNK pathway

Shijie Xu, Xianhua Xu, Junzhe Li, 2020, Biology Open.

Discordance between anaplastic lymphoma kinase status in primary non‐small‐cell lung cancers and their corresponding metastases

Yan-Ze Jin, C. Lee, Hyojin Kim, 2013, Histopathology.

Loss of PTEN Expression is an Independent Poor Prognostic Factor in Non-small Cell Lung Cancer

H. Lee, C. Lee, G. Choe, 2010 .

Wnt7a inhibits transformed cell proliferation while promoting migration and invasion in non-small cell lung cancer

Shijie Xu, Xianhua Xu, Junzhe Li, 2020, Translational cancer research.

Biphasic function of GSK3β in gefitinib‑resistant NSCLC with or without EGFR mutations

Xianhua Xu, Junzhe Li, Xiayu Wu, 2023, Experimental and therapeutic medicine.